Patents by Inventor Agnes Thomas-Collignon

Agnes Thomas-Collignon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Process for treating an individual with an esthetic defect of skin by modulating SASPase FLG2 complex
    Patent number: 9869681
    Abstract: The present invention relates to the use of a compound, suitable for modulating the interaction between first and second partner proteins, or between homologues, mutants, or fragments of said proteins, said first and second proteins being SASPase and filaggrin-2, or FLG2, as an active agent for treating and/or preventing aesthetic defects in the skin, and/or in the appendages thereof, linked to an imbalance in the differentiation and/or proliferation of the cells of the epidermis.
    Type: Grant
    Filed: December 5, 2011
    Date of Patent: January 16, 2018
    Assignee: L'OREAL
    Inventors: Dominique Bernard, Agnes Thomas-Collignon, Roger Rozot, Benoit Muller
  • Substituted pyrido[2,3-d]pyrimidines for dry skin and anti-ageing application
    Patent number: 9464080
    Abstract: The present invention relates to the cosmetic use, as agent for preventing and/or treating an aesthetic defect in the skin and/or its appendages that is associated with an imbalance in the differentiation and/or proliferation of the cells of an epidermis, of an effective amount of at least one compound represented by one of the general formulae, (Ia) or (Ib)
    Type: Grant
    Filed: June 5, 2013
    Date of Patent: October 11, 2016
    Assignee: L'Oreal
    Inventors: Xavier Marat, Benoit Muller, Agnès Thomas-Collignon, Dominique Bernard
  • Peptides that modulate complex SASPase-FLG2
    Patent number: 9290553
    Abstract: An isolated peptide from skin aspartic protease (SASPase) or filaggrin-2 (FLG2), a fragment or homologue thereof, which can modify the three-dimensional shape of a complex formed by interaction between a first amino acid sequence from filaggrin-2 and a second amino acid sequence from SASPase, is described. The isolated peptide is useful as a target for screening for cosmetic or therapeutic active agents with regard to the skin and/or its appendages.
    Type: Grant
    Filed: December 5, 2011
    Date of Patent: March 22, 2016
    Assignee: L'OREAL
    Inventors: Dominique Bernard, Agnes Thomas-Collignon
  • ACTIVE COMPOUNDS FOR COMBATING GREASY SKIN
    Publication number: 20150152101
    Abstract: The present invention relates to the cosmetic use, as an agent for preventing and/or treating greasy skin or greasy-prone skin and/or an associated aesthetic skin disorder, of an effective amount of at least one compound represented by either of the general formulae (Ia) and (Ib).
    Type: Application
    Filed: June 5, 2013
    Publication date: June 4, 2015
    Applicant: L'OREAL
    Inventors: Xavier Marat, Benoit Muller, Agnes Thomas-Collignon, Dominique Bernard
  • COMPOUNDS FOR DRY SKIN AND ANTI-AGEING APPLICATION
    Publication number: 20150148356
    Abstract: The present invention relates to the cosmetic use, as agent for preventing and/or treating an aesthetic defect in the skin and/or its appendages that is associated with an imbalance in the differentiation and/or proliferation of the cells of an epidermis, of an effective amount of at least one compound represented by one of the general formulae, (Ia) or (Ib)
    Type: Application
    Filed: June 5, 2013
    Publication date: May 28, 2015
    Inventors: Xavier Marat, Benoit Muller, Agnès Thomas-Collignon, Dominique Bernard
  • SASPASE-FLG2 COMPLEX, MODULATING AGENTS, AND USES
    Publication number: 20140005207
    Abstract: The present invention relates to the use of a compound, suitable for modulating the interaction between first and second partner proteins, or between homologues, mutants, or fragments of said proteins, said first and second proteins being SASPase and filaggrin-2, or FLG2, as an active agent for treating and/or preventing aesthetic defects in the skin, and/or in the appendages thereof, linked to an imbalance in the differentiation and/or proliferation of the cells of the epidermis.
    Type: Application
    Filed: December 5, 2011
    Publication date: January 2, 2014
    Applicant: L'OREAL
    Inventors: Dominique Bernard, Agnes Thomas-Collignon, Roger Rozot, Benoit Muller
  • PEPTIDES THAT MODULATE COMPLEX SASPASE-FLG2
    Publication number: 20130324477
    Abstract: The invention relates to a peptide isolated from SASpase or FLG2, a fragment or homologue thereof, which can modify the three-dimensional shape of a complex formed by interaction between a first amino acide sequence from Filaggrin-2 and a second amino acid sequence from SASPase.
    Type: Application
    Filed: December 5, 2011
    Publication date: December 5, 2013
    Applicant: L'OREAL
    Inventors: Dominique Bernard, Agnes Thomas-Collignon